Moneta Group Investment Advisors LLC trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,614 shares of the healthcare conglomerate’s stock after selling 249 shares during the period. Moneta Group Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,614,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Eastern Bank raised its position in UnitedHealth Group by 2.0% during the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after acquiring an additional 1,375 shares during the period. Enterprise Bank & Trust Co acquired a new stake in shares of UnitedHealth Group during the 1st quarter valued at approximately $3,785,000. Private Advisors LLC raised its position in shares of UnitedHealth Group by 57.9% during the 1st quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock valued at $1,607,000 after acquiring an additional 2,385 shares in the last quarter. Capital Investment Advisors LLC raised its position in shares of UnitedHealth Group by 26.2% during the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock valued at $1,556,000 after acquiring an additional 1,323 shares in the last quarter. Finally, Berkeley Capital Partners LLC raised its position in shares of UnitedHealth Group by 7.4% during the 2nd quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock valued at $542,000 after acquiring an additional 153 shares in the last quarter. Institutional investors and hedge funds own 85.66% of the company’s stock.
Several equities research analysts recently issued reports on UNH shares. ValuEngine lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Thursday, September 5th. Oppenheimer set a $312.00 price target on UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Raymond James upped their price target on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target on the stock in a research report on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seventeen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $291.61.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. During the same period last year, the company earned $3.14 earnings per share. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.95%. The ex-dividend date was Friday, September 13th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
In other news, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $233.40, for a total value of $583,500.00. Following the transaction, the director now directly owns 187,979 shares in the company, valued at $43,874,298.60. The disclosure for this sale can be found here. Insiders have sold 24,000 shares of company stock worth $5,924,120 over the last three months. Corporate insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Using the New Google Finance Tool
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.